Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: ZJYL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 34.41% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 101.74M USD | Price to earnings Ratio 32.49 | 1Y Target Price - |
Price to earnings Ratio 32.49 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 10.76 | 52 Weeks Range 0.56 - 4.38 | Updated Date 06/29/2025 |
52 Weeks Range 0.56 - 4.38 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.02 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 15.64% | Operating Margin (TTM) 18.61% |
Management Effectiveness
Return on Assets (TTM) 5.78% | Return on Equity (TTM) 13.02% |
Valuation
Trailing PE 32.49 | Forward PE - | Enterprise Value 86163622 | Price to Sales(TTM) 4.33 |
Enterprise Value 86163622 | Price to Sales(TTM) 4.33 | ||
Enterprise Value to Revenue 3.67 | Enterprise Value to EBITDA 21.62 | Shares Outstanding 156547008 | Shares Floating 37824910 |
Shares Outstanding 156547008 | Shares Floating 37824910 | ||
Percent Insiders 75.84 | Percent Institutions 0.64 |
Upturn AI SWOT
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Company Overview
History and Background
JIN MEDICAL INTERNATIONAL LTD. is a holding company that manufactures and sells rehabilitation and home healthcare products in China and internationally. Founded to address the growing demand for accessible medical solutions, it has expanded its product line and market reach.
Core Business Areas
- Rehabilitation Products: Includes wheelchairs, mobility scooters, and other devices designed to aid in physical rehabilitation.
- Home Healthcare Products: Encompasses products like hospital beds, oxygen concentrators, and other equipment used for in-home medical care.
Leadership and Structure
Details regarding JIN MEDICAL INTERNATIONAL LTD.'s leadership team and organizational structure are limited in publicly available resources. Further research would be required.
Top Products and Market Share
Key Offerings
- Wheelchairs: JIN MEDICAL offers various types of wheelchairs. Specific market share data is not readily available. Competitors include Invacare (IVC), Permobil, and Sunrise Medical.
- Mobility Scooters: Designed for ease of use. Specific market share data is not readily available. Competitors include Pride Mobility Products, Drive DeVilbiss Healthcare, and Golden Technologies.
Market Dynamics
Industry Overview
The rehabilitation and home healthcare products industry is experiencing growth due to an aging population, increasing prevalence of chronic diseases, and a shift towards home-based care.
Positioning
JIN MEDICAL aims to provide affordable rehabilitation and home healthcare solutions, primarily targeting the Chinese market and expanding internationally. Competitive advantages depend on price, product availability, and distribution networks.
Total Addressable Market (TAM)
The global medical device market is in the hundreds of billions USD. JIN MEDICAL INTERNATIONAL LTD. targets a specific niche within this larger market, primarily the rehabilitation and home healthcare segments. Their positioning within this TAM is focused on affordability and accessibility, particularly within the Chinese market, and expanding into international markets as well.
Upturn SWOT Analysis
Strengths
- Established presence in the Chinese market
- Focus on affordable products
- Diversified product line
Weaknesses
- Limited brand recognition outside of China
- Dependence on specific geographic markets
- Smaller scale compared to global competitors
Opportunities
- Expanding into new geographic markets
- Developing innovative product offerings
- Partnerships and acquisitions to broaden market reach
Threats
- Increased competition from established players
- Regulatory changes in healthcare policies
- Economic downturns affecting consumer spending
Competitors and Market Share
Key Competitors
- IVC
- PRIDE
- PERMOBIL
Competitive Landscape
JIN MEDICAL faces competition from global medical device manufacturers. Its competitive advantage relies on affordability and a strong presence in China, but it needs to enhance brand recognition internationally.
Growth Trajectory and Initiatives
Historical Growth: Information on historical growth is unavailable without financial data, but it's expected they are looking to expand internationally
Future Projections: Analyst estimates for JIN MEDICAL's future growth are not available, making an estimation of future projections difficult.
Recent Initiatives: Detailed information on recent strategic initiatives is not readily available, and requires dedicated financial research.
Summary
JIN MEDICAL INTERNATIONAL LTD. focuses on affordable rehabilitation and home healthcare products, primarily within China. While it has an established presence there, its limited brand recognition outside China and smaller scale compared to global competitors pose challenges. Opportunities exist through international expansion and innovative product development, but increased competition and regulatory changes remain threats. The company's financial health and future performance require further analysis based on available financial statements and analyst projections.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Public News Articles
- Industry Reports
Disclaimers:
The information provided is based on publicly available sources and may not be entirely accurate or complete. This analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2023-03-28 | Chairman of the Board, President & CEO Mr. Erqi Wang | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 269 | Website https://www.zhjmedical.com |
Full time employees 269 | Website https://www.zhjmedical.com | ||
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.